Prescription Drug Marketing Act (PDMA) Requirements- Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 15, 2006
April 8, 2020
e1169199-071c-4b63-b38b-60b57b79d4e6
Related Documents
Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1
Guidance DocumentJune 15, 1998Center for Drug Evaluation and Research
Changes to an Approved NDA or ANDA: Questions and Answers: Guidance for Industry
Guidance DocumentJanuary 1, 2001Center for Drug Evaluation and Research
Labeling OTC Human Drug Products Using a Column Format
Guidance DocumentDecember 19, 2000Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.